Clinical pharmacokinetics of high-dose DTIC
- 1 January 1991
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 28 (6) , 475-479
- https://doi.org/10.1007/bf00685826
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Investigation of the mechanism of action of antitumour dimethyltriazenesBiochimie, 1978
- Effects of 4(5)-(3,3-dimethyl-1-triazeno)-imidazole-5(4)-carboxamide (NSC 45388) in proliferating rat tissuesBiochemical Pharmacology, 1972
- Mechanism of action of 5-(3,3-dimethyl-1-triazeno)imidazole-4-caboxamide in mammalian cells in cultureBiochemical Pharmacology, 1972
- Combination Phase 1 -II Study of Imidazole Carboxamide (NCS 45388)Oncology, 1972
- Syntheses and Biological Activity of 5-Aminoimidazoles and 5-TriazenoimidazolesJournal of Pharmaceutical Sciences, 1970
- Metabolism of 4(5)-(3,3-dimethyl-1-triazeno)imidazole-5(4)-carboxamide to 4(5)-aminoimidazole-5(4)-carboxamide in manBiochemical Pharmacology, 1970
- Assessment of Pharmacokinetic Constants from Postinfusion Blood Curves Obtained after I.V. InfusionJournal of Pharmaceutical Sciences, 1970
- Estimation of the pharmacokinetic parameters of the two-compartment open model from post-infusion plasma concentration dataJournal of Pharmaceutical Sciences, 1969
- Mechanism of carcinogenesis with 1-Aryl-3,3-dialkyltriazenes. Enzymatic dealkylation by rat liver microsomal fraction in vitroBiochemical Pharmacology, 1969
- Some Pharmacokinetic Aspects of 5-(Dimethyltriazeno)-imidazole-4-carboxamide in the DogJournal of Pharmaceutical Sciences, 1968